These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28752270)

  • 1. Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network.
    Mahjoub MA; Bakhshinejad B; Sadeghizadeh M; Babashah S
    Mol Biol Rep; 2017 Aug; 44(4):341-351. PubMed ID: 28752270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
    Baghi N; Bakhshinejad B; Keshavarz R; Babashah S; Sadeghizadeh M
    Gene; 2018 Sep; 670():55-62. PubMed ID: 29753810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on combination of oxaliplatin and dendrosomal nanocurcumin on proliferation, apoptosis induction, and long non-coding RNA expression in ovarian cancer cells.
    Seyed Hosseini E; Alizadeh Zarei M; Babashah S; Nakhaei Sistani R; Sadeghizadeh M; Haddad Kashani H; Amini Mahabadi J; Izadpanah F; Atlasi MA; Nikzad H
    Cell Biol Toxicol; 2019 Jun; 35(3):247-266. PubMed ID: 30478652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
    Yu LL; Wu JG; Dai N; Yu HG; Si JM
    Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of dendrosomal curcumin on an animal metastatic breast tumor.
    Farhangi B; Alizadeh AM; Khodayari H; Khodayari S; Dehghan MJ; Khori V; Heidarzadeh A; Khaniki M; Sadeghiezadeh M; Najafi F
    Eur J Pharmacol; 2015 Jul; 758():188-96. PubMed ID: 25863259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of lncRNA, GAS5 decreases chemotherapeutic effect of dendrosomal curcumin (DNC) in breast cancer cells.
    Esmatabadi MJD; Motamedrad M; Sadeghizadeh M
    Phytomedicine; 2018 Mar; 42():56-65. PubMed ID: 29655698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendrosomal nanocurcumin and p53 overexpression synergistically trigger apoptosis in glioblastoma cells.
    Keshavarz R; Bakhshinejad B; Babashah S; Baghi N; Sadeghizadeh M
    Iran J Basic Med Sci; 2016 Dec; 19(12):1353-1362. PubMed ID: 28096969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgolic acids inhibit migration in breast cancer cells by inhibition of NEMO sumoylation and NF-κB activity.
    Hamdoun S; Efferth T
    Oncotarget; 2017 May; 8(21):35103-35115. PubMed ID: 28402272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs.
    Seyed Hosseini E; Alizadeh Zarei M; Tarrahimofrad H; Zamani J; Haddad Kashani H; Ahmad E; Nikzad H
    Biol Res; 2023 Jan; 56(1):3. PubMed ID: 36658640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells.
    Shi Y; Yu Y; Wang Z; Wang H; Bieerkehazhi S; Zhao Y; Suzuk L; Zhang H
    Oncotarget; 2016 Nov; 7(45):73697-73710. PubMed ID: 27655642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
    Alinejad V; Hossein Somi M; Baradaran B; Akbarzadeh P; Atyabi F; Kazerooni H; Samadi Kafil H; Aghebati Maleki L; Siah Mansouri H; Yousefi M
    Biomed Pharmacother; 2016 Oct; 83():229-240. PubMed ID: 27372407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
    Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB
    Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
    Rai G; Mishra S; Suman S; Shukla Y
    Phytomedicine; 2016 Mar; 23(3):233-42. PubMed ID: 26969377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
    Kang HJ; Lee SH; Price JE; Kim LS
    Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines.
    Montazeri M; Sadeghizadeh M; Pilehvar-Soltanahmadi Y; Zarghami F; Khodi S; Mohaghegh M; Sadeghzadeh H; Zarghami N
    Int J Pharm; 2016 Jul; 509(1-2):244-254. PubMed ID: 27234697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin and paclitaxel induce cell death in breast cancer cell lines.
    Calaf GM; Ponce-Cusi R; Carrión F
    Oncol Rep; 2018 Oct; 40(4):2381-2388. PubMed ID: 30066930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.
    Chougule MB; Patel AR; Jackson T; Singh M
    PLoS One; 2011 Mar; 6(3):e17733. PubMed ID: 21423660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.
    Chang YW; Chen MW; Chiu CF; Hong CC; Cheng CC; Hsiao M; Chen CA; Wei LH; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S687-95. PubMed ID: 25047463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.